{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:17:59Z","timestamp":1793222279910,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":15,"publisher":"Springer US","isbn-type":[{"value":"9781071619551","type":"print"},{"value":"9781071619568","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1956-8_5","type":"book-chapter","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T20:02:44Z","timestamp":1639684964000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Processing and Analysis of Ascites"],"prefix":"10.1007","author":[{"given":"Hannah M.","family":"Micek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly J.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Barroilhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela K.","family":"Kreeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL (2013) Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol 3:256. https:\/\/doi.org\/10.3389\/fonc.2013.00256","journal-title":"Front Oncol"},{"issue":"3","key":"5_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ygyno.2017.06.008","volume":"146","author":"JB Szender","year":"2017","unstructured":"Szender JB, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K, Khan A, Singel KL, Mayor PC, Moysich KB, Odunsi K, Segal BH, Eng KH (2017) Impact of ascites volume on clinical outcomes in ovarian cancer: a cohort study. Gynecol Oncol 146(3):491\u2013497. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.008","journal-title":"Gynecol Oncol"},{"issue":"50","key":"5_CR3","doi-asserted-by":"publisher","first-page":"83148","DOI":"10.18632\/oncotarget.13074","volume":"7","author":"S Kim","year":"2016","unstructured":"Kim S, Gwak H, Kim HS, Kim B, Dhanasekaran DN, Song YS (2016) Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget 7(50):83148\u201383159. https:\/\/doi.org\/10.18632\/oncotarget.13074","journal-title":"Oncotarget"},{"issue":"13","key":"5_CR4","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1158\/0008-5472.CAN-17-3341","volume":"78","author":"MJ Carroll","year":"2018","unstructured":"Carroll MJ, Fogg KC, Patel HA, Krause HB, Mancha AS, Patankar MS, Weisman PS, Barroilhet L, Kreeger PK (2018) Alternatively-activated macrophages upregulate mesothelial expression of P-selectin to enhance adhesion of ovarian cancer cells. Cancer Res 78(13):3560\u20133573. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3341","journal-title":"Cancer Res"},{"issue":"2","key":"5_CR5","first-page":"259","volume":"51","author":"O Soritau","year":"2010","unstructured":"Soritau O, Tomuleasa CI, Pall E, Virag P, Fischer-Fodor E, Foris V, Barbos O, Tatomir C, Kacso G, Irimie A (2010) Enhanced chemoresistance and tumor sphere formation as a laboratory model for peritoneal micrometastasis in epithelial ovarian cancer. Romanian J Morphol Embryol 51(2):259\u2013264","journal-title":"Romanian J Morphol Embryol"},{"issue":"12","key":"5_CR6","first-page":"2388","volume":"57","author":"A Frankel","year":"1997","unstructured":"Frankel A, Buckman R, Kerbel RS (1997) Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res 57(12):2388\u20132393","journal-title":"Cancer Res"},{"issue":"37","key":"5_CR7","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","volume":"37","author":"S Al Habyan","year":"2018","unstructured":"Al Habyan S, Kalos C, Szymborski J, McCaffrey L (2018) Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene 37(37):5127\u20135135. https:\/\/doi.org\/10.1038\/s41388-018-0317-x","journal-title":"Oncogene"},{"issue":"1","key":"5_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2015.04.014","volume":"138","author":"S Raghavan","year":"2015","unstructured":"Raghavan S, Ward MR, Rowley KR, Wold RM, Takayama S, Buckanovich RJ, Mehta G (2015) Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays. Gynecol Oncol 138(1):181\u2013189. https:\/\/doi.org\/10.1016\/j.ygyno.2015.04.014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1021\/acsbiomaterials.7b00069","volume":"4","author":"MF Gencoglu","year":"2018","unstructured":"Gencoglu MF, Barney LE, Hall CL, Brooks EA, Schwartz AD, Corbett DC, Stevens KR, Peyton SR (2018) Comparative study of multicellular tumor spheroid formation methods and implications for drug screening. ACS Biomater Sci Eng 4(2):410\u2013420. https:\/\/doi.org\/10.1021\/acsbiomaterials.7b00069","journal-title":"ACS Biomater Sci Eng"},{"issue":"10","key":"5_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046858","volume":"7","author":"A Latifi","year":"2012","unstructured":"Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, Zhu H, Thompson EW, Quinn MA, Findlay JK, Ahmed N (2012) Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One 7(10):e46858. https:\/\/doi.org\/10.1371\/journal.pone.0046858","journal-title":"PLoS One"},{"issue":"2","key":"5_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ijc.2910350211","volume":"35","author":"JG Collard","year":"1985","unstructured":"Collard JG, van Beek WP, Janssen JW, Schijven JF (1985) Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations. Int J Cancer 35(2):207\u2013213. https:\/\/doi.org\/10.1002\/ijc.2910350211","journal-title":"Int J Cancer"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/B978-0-12-420067-8.00018-0","volume":"533","author":"CM Koh","year":"2013","unstructured":"Koh CM (2013) Preparation of cells for microscopy using \u2018cell blocks\u2019. Methods Enzymol 533:249\u2013255. https:\/\/doi.org\/10.1016\/B978-0-12-420067-8.00018-0","journal-title":"Methods Enzymol"},{"issue":"5","key":"5_CR13","first-page":"566","volume":"2","author":"I Matte","year":"2012","unstructured":"Matte I, Lane D, Laplante C, Rancourt C, Piche A (2012) Profiling of cytokines in human epithelial ovarian cancer ascites. Am J Cancer Res 2(5):566\u2013580","journal-title":"Am J Cancer Res"},{"issue":"7","key":"5_CR14","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/1097-0142(19940401)73:7<1882::aid-cncr2820730718>3.0.co;2-r","volume":"73","author":"M Plante","year":"1994","unstructured":"Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gastl GA (1994) Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 73(7):1882\u20131888. https:\/\/doi.org\/10.1002\/1097-0142(19940401)73:7<1882::aid-cncr2820730718>3.0.co;2-r","journal-title":"Cancer"},{"issue":"19","key":"5_CR15","first-page":"5334","volume":"60","author":"S Huang","year":"2000","unstructured":"Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ (2000) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60(19):5334\u20135339","journal-title":"Cancer Res"}],"container-title":["Methods in Molecular Biology","Ovarian Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1956-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:47:09Z","timestamp":1662169629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1956-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"ISBN":["9781071619551","9781071619568"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1956-8_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"17 December 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}